TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/8/24 20:02 | 11/6/24 | APGE | Apogee Therapeutics, Inc. | Health | BioPrd | Biological Products, (No Diag | Dambkowski Carl | MA | O | Chief Me | S | -394 | 59.12 | 0 | -7 | -2 | 267 | D | |||||||||||||||
10/4/24 20:02 | 10/2/24 | APGE | Apogee Therapeutics, Inc. | Health | BioPrd | Biological Products, (No Diag | Dambkowski Carl | MA | O | Chief Me | S | -375 | 56.26 | 0 | -7 | -2 | 274 | D | |||||||||||||||
9/6/24 20:03 | 9/4/24 | APGE | Apogee Therapeutics, Inc. | Health | BioPrd | Biological Products, (No Diag | Dambkowski Carl | MA | O | Chief Me | S | -317 | 47.56 | 0 | -7 | -2 | 281 | D | |||||||||||||||
8/9/24 20:05 | 8/7/24 | APGE | Apogee Therapeutics, Inc. | Health | BioPrd | Biological Products, (No Diag | Dambkowski Carl | MA | O | Chief Me | S | -298 | 40.67 | 0 | -7 | -2 | 287 | D | |||||||||||||||
7/5/24 20:01 | 7/3/24 | APGE | Apogee Therapeutics, Inc. | Health | BioPrd | Biological Products, (No Diag | Dambkowski Carl | MA | O | Chief Me | S | -225 | 37.60 | 0 | -6 | -2 | 295 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |